EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Given Average Rating of “Buy” by Brokerages

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) have received a consensus recommendation of “Buy” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company.

Several equities research analysts recently weighed in on the company. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday, January 14th. Citigroup reiterated a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. UBS Group upgraded shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 27th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Finally, Kepler Capital Markets upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday, January 15th.

EssilorLuxottica Trading Up 0.6%

ESLOY stock opened at $112.68 on Friday. EssilorLuxottica has a fifty-two week low of $111.22 and a fifty-two week high of $186.81. The business’s 50 day moving average price is $141.25 and its two-hundred day moving average price is $159.12. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.